Whether these cancer stem cells are able to upregulate Lgr5 expression in a BMAL1 independent manner and how BMAL1, MEX3A and Lgr5 regulatory relationship in colorectal cancer stem cells differs from that in non-cancerous intestinal tissue will also be of interest for further investigation. This evidence concerns the gene MEX3A and colorectal cancer.